EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Therapeutic Potential of Specific Lacticaseibacillus rhamnosus Strains for DNCB-Induced Atopic Dermatitis in Mice

Tingchao He iD, Qidong Lu, Jian Zhang, Xinyu Xie, Xin Liu, Hua Jiang iD, Jing Li, Yumei Zhang iD

Nutrients · 23.04.2026 · 18 (9) · 1335

DOI: 10.3390/nu18091335 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 23.04.2026. Verfasst von Tingchao He und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Food Hygiene, School of Public Health, Peking University, Beijing 100191, China. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Lacticaseibacillus rhamnosus, Probiotics. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Beijing Natural Science Foundation, Grants-in-Aids for Young Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Atopic dermatitis (AD) is a chronic inflammatory skin disease linked to epidermal barrier dysfunction, Th2-skewed immune polarization, and disrupted gut microbiota homeostasis. While probiotic interventions show promise in managing AD, the mechanisms governing strain-specific efficacy—particularly systemic modulation via the “gut–skin axis”—remaining to be fully elucidated.

Methods

This study systematically compared the oral therapeutic effects of three Lacticaseibacillus rhamnosus strains (MG-A047, MG-A054, and LGG) in a 2,4-dinitrochlorobenzene (DNCB)-induced AD mouse model.

Results

By integrating behavioral, histopathological, and serological assessments with 16S rRNA-based gut microbiota profiling and in vitro functional assays, this study offers a multidimensional evaluation of the strain-specific advantages and potential therapeutic mechanisms of three L. rhamnosus strains. The results demonstrate that MG-A054 most effectively alleviated cutaneous inflammation and pruritus, significantly reduced serum IgE and IL-4 levels, and attenuated epidermal hyperplasia and inflammatory cell infiltration (including mast cells and eosinophils). Mechanistically, this strain may directly inhibit hyaluronidase activity and mast cell degranulation, and specifically remodel the gut microbiota structure, thereby promoting a shift toward a healthier functional profile.

Conclusions

These findings suggest that the superior efficacy of MG-A054 may be achieved through coordinated modulation of the gut–skin axis and related pathways. This study offers new mechanistic clues for understanding the strain-specific actions of probiotics and lays a preclinical foundation for the further development of MG-A054 as a potential targeted microecological therapy for AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicLacticaseibacillus rhamnosusProbioticsAnimalsDinitrochlorobenzeneMiceDisease Models, AnimalImmunoglobulin EGastrointestinal MicrobiomeInterleukin-4SkinMaleMast CellsFemaleMice, Inbred BALB C

Stichwörter der Autor:innen

Lacticaseibacillus rhamnosusatopic dermatitisgut microbiota

Substanzen

DinitrochlorobenzeneImmunoglobulin EInterleukin-4

Autor:innen und Institutionen

  • Department of Nutrition and Food Hygiene, School of Public Health, Peking University, Beijing 100191, China.
  • Department of Hygiene, Fujita Health University, Toyoake-shi 470-1192, Japan.
  • Mom's Garden Institute of Nutrition and Health, Bismarckstraße 37, 66121 Saarbrücken, Germany.
  • School of Nursing, Peking University, Beijing 100191, China.

ORCID-Profile: Tingchao He, Hua Jiang, Yumei Zhang

Förderung

  • National Key Research and Development Program of China
  • Beijing Natural Science Foundation
  • Grants-in-Aids for Young Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)
  • Ministry of Education, Culture, Sports, Science and Technology

Zitieren

APA

He, T., Lu, Q., Zhang, J., Xie, X., Liu, X., Jiang, H., Li, J., & Zhang, Y. (2026). Therapeutic Potential of Specific Lacticaseibacillus rhamnosus Strains for DNCB-Induced Atopic Dermatitis in Mice. Nutrients, 18(9), 1335. https://doi.org/10.3390/nu18091335

Vancouver

He T, Lu Q, Zhang J, Xie X, Liu X, Jiang H, et al. Therapeutic Potential of Specific Lacticaseibacillus rhamnosus Strains for DNCB-Induced Atopic Dermatitis in Mice. Nutrients. 2026;18(9):1335. doi:10.3390/nu18091335

BibTeX
@article{He2026,
  author = {He, Tingchao and Lu, Qidong and Zhang, Jian and Xie, Xinyu and Liu, Xin and Jiang, Hua and Li, Jing and Zhang, Yumei},
  title = {Therapeutic Potential of Specific Lacticaseibacillus rhamnosus Strains for DNCB-Induced Atopic Dermatitis in Mice},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {9},
  pages = {1335},
  doi = {10.3390/nu18091335}
}
Kostenlos starten →